Virag Dandekar

669 citations
6 papers · 527 indexed · h-index 4
Topics
Management of metastatic bone disease (4 papers)Endometrial and Cervical Cancer Treatments (2 papers)Head and Neck Cancer Studies (2 papers)
Partner nations
United States

In The Last Decade

Virag Dandekar

6 papers receiving 515 citations

Peers

Virag Dandekar
Comparison fields: 5 of 57
  • Oncology 234
  • Surgery 168
  • Pulmonary and Respiratory Medicine 151
  • Otorhinolaryngology 113
  • Molecular Biology 109
Replace Yalan Tao with:
Yalan Tao China
Sonali Rudra United States
G. Haensgen Germany
Ji Hyeon Joo South Korea
A. Reynaud-Bougnoux France
Su Jung Shim South Korea
Renuka Malik United States
Hyung Jun Yoo South Korea
Peter C. Ungaro United States
Colin Trask United Kingdom
Virag Dandekar relative to Yalan Tao China Yalan Tao's profile →
Citations per field
00.5×1.5×1.9×
Yalan Tao · 1×
Citations per year

Countries citing papers authored by Virag Dandekar

Since Specialization
Citations

This map shows the geographic impact of Virag Dandekar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virag Dandekar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virag Dandekar more than expected).

Fields of papers citing papers by Virag Dandekar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virag Dandekar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virag Dandekar. The network helps show where Virag Dandekar may publish in the future.

Co-authorship network of co-authors of Virag Dandekar

This figure shows the co-authorship network connecting the top 25 collaborators of Virag Dandekar. A scholar is included among the top collaborators of Virag Dandekar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virag Dandekar. Virag Dandekar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
#WorkIndexed citations
1 6
2 3
3 25
4 1
5 144
6 348

About Virag Dandekar

Virag Dandekar is a scholar working on Otorhinolaryngology, Obstetrics and Gynecology and Surgery, having authored 6 papers that have together received 527 indexed citations. Recurring topics across this work include Management of metastatic bone disease (4 papers), Endometrial and Cervical Cancer Treatments (2 papers) and Head and Neck Cancer Studies (2 papers). The work is most often cited by research in Otorhinolaryngology (113 citations), Obstetrics and Gynecology (104 citations) and Oncology (234 citations). Virag Dandekar has collaborated with scholars based in United States. Frequent co-authors include Loren K. Mell, Joseph K. Salama, Ezra E.W. Cohen, Blasé N. Polite, James J. Dignam, Mary Ellyn Witt, Ralph R. Weichselbaum, Bharat B. Mittal, Daniel J. Haraf and Everett E. Vokes. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Oral Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026